![Caroline Baumal](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Caroline Baumal
Chief Tech/Sci/R&D Officer at
APELLIS PHARMACEUTICALS, INC.
Profile
Caroline Baumal currently works at Apellis Pharmaceuticals, Inc., as Chief Medical Officer from 2023 and New England Eye Center, as Professor.
Dr. Baumal received her doctorate degree from the University of Toronto.
Caroline Baumal active positions
| Companies | Position | Start |
|---|---|---|
| APELLIS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 02/01/2023 |
New England Eye Center
 New England Eye Center Medical/Nursing ServicesHealth Services Provides ophthalmology care services | Corporate Officer/Principal | 31/12/1997 |
Training of Caroline Baumal
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
15
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Apellis Pharmaceuticals, Inc.
 Apellis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics and drug delivery technologies to address chronic inflammatory diseases | Health Technology |
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Toronto
 University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New England Eye Center
New England Eye Center Medical/Nursing ServicesHealth Services Provides ophthalmology care services | Health Services |
- Stock Market
- Insiders
- Caroline Baumal
